Categories: BatteryChemicalChemicalsEnergyTechHouseholdIndustryITScienceWaterTech
We use electrons to capture carbon dioxide from the atmosphere
Investors 2
Persons 4
Mentions in press and media 6
| Date | Title | Description |
| 24.06.2021 | Holy Grail secures USD 2.7 Million in the seed round | California-based Holy Grail raises USD 2.7 Million in a seed funding round on Wednesday, June 23rd 2021. This round was led by LowerCarbon Capital; Patrick Collison, Founder, Stripe; Kyle Vogt, co-Founder, Cruise; Goat Capital; Starlight Ve... |
| 23.06.2021 | Daily funding roundup - June 22nd, 2021 | Gloat raised $57M; Sporttrade landed $36M; Majority secured $19M, Coinme picks up $10M
G2: G2 is a Chicago-based software marketplace that features peer reviews that help simplify the buying process. G2 raised $157 million in Series D fundi... |
| 22.06.2021 | Holy Grail raises $2.7M seed fund to create modular carbon capture devices | The founders of Holy Grail, a two-year-old startup based in Mountain View, California, are taking a micro approach to solving the outsized problem of capturing carbon.
The startup is prototyping a direct air carbon capture device that is mo... |
| 19.08.2019 | All 84 startups from Y Combinator’s S19 Demo Day 1 | It’s that time of year, Silicon Valley’s investor technocrati and advice-giving Twitter celebrities descended upon Pier 48 in San Francisco to judge the latest summer batch of Y Combinator startups. TechCrunch was there, as well, and we wer... |
| 16.08.2019 | Y Combinator-backed Holy Grail is using machine learning to build better batteries | For a long, long time, renewable energy proponents have considered advancements in battery technology to be the Holy Grail of the industry.
Advancements in energy storage has been among the hardest to achieve economically, thanks to the inc... |
| 15.01.2018 | Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab | Vaccitech isn’t just going after one of the Holy Grails in biotech R&D. It’s taking aim at two of them.
A spinout from some leading vaccine experts at Oxford’s Jenner Institute, the startup has been following up on new re... |
Reviews 0
